
|Articles|October 19, 2009
Emerging Pharma Leadership Awards - Luca Santarelli
Advertisement
Luca Santarelli,
Global Head of Clinical Research and Exploratory Development in CNS,
Roche
Download Adobe Flash Player
“Most innovation happens at the boundaries between different disciplines, and I’m sitting at the boundary between clinicians who work with a drug label and researchers who work with a wide array of targets.” Listen to the Podcast for more coverage.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Evolving Relationship Between FDA and Biotech
4
What Kinds of Disruption are GLP-1s Expected to Face
5




